Active, Not Recruiting
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT02845323
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- UCLA Institute of Urologic Oncology Los Angeles, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- University of Chicago Chicago, Illinois, United States
- Johns Hopkins Hospital Baltimore, Maryland, United States